GraysonWL, MartensTP, EngGM, et al.. Semin Cell Dev Biol, 2009 Aug;20(6):665–673.
2.
BregenzerME, HorstEN, MehtaP, et al.. PLoS One, 2019 May 10;14(5):e0216564.
3.
WuZ, HuangD, WangJ, et al.. Adv Sci, 2024, 11; 2304160.
4.
CarnevaliF, ForcinitiS, OnestoV, et al.. Adv Therap, 2024, 7; 2400351.
5.
JiE, Germendia UrdalletaA, Witte-BoumaJ, et al.. Tissue Eng Part C Methods, 2026 Feb 19:19373341251378152.
6.
SuurmondCE, van DijkNWM, van RhedenR, et al.. Tissue Eng Part C Methods, 2026 Feb 28:19373384261422836.
7.
FreemanS & SlaterJ. Tissue Eng Part C Methods.
8.
FaberA, NejatS, BakerJ & ZustiakSP. Tissue Eng Part C Methods.
9.
LightseyS, et al. Tissue Eng Part C Methods.
10.
The Size of Glioblastoma Spheroids Influences Patterns of Invasion and Temozolomide Efficacy. Fok S, Shreesha A, Appiah-Kubi A, Riggins RB, Harley BAC. Tissue Eng Part C Methods. 2026 Mar 16:19373384261432672; doi: 10.1177/19373384261432672.
